Cetuximab Helps Treat Colorectal Cancer:
Links shared publicly online about this topic.
- 1,576total visits
Cetuximab Helps Treat Colorectal Cancer:
View full resource at health.msn.com
Tags: Cancer, Rectal Cancer, Colon Cancer, Erbitux
Most Recently Shared on November 25, 2009 at 5:46 pm By:
Cetuximab Helps Treat Colorectal Cancer: http://bit.ly/8Adnhc
Combining RNA Interference With Tyrosine Kinase Inhibitors Or Cetuximab Enhances Lung Cancer Therapy
medicalnewstoday.com — “Non-small cell lung cancer (NSCLC), the most common form of lung cancer, is usually treated with surgery and chemotherapy. However, a small group of patients can also be helped by treatment with t” View full resource at medicalnewstoday.com
Most Recently Shared on March 21, 2012 at 8:05 am By:
Combining RNA Interference With Tyrosine Kinase Inhibitors Or Cetuximab Enhances Lung Cancer Therapy: Non-small ... http://t.co/nfOz9EY5
Jennerex initiates JX-594 plus irinotecan Phase 1/2 trial in metastatic colorectal cancer
news-medical.net — “Jennerex, Inc., a private clinical-stage biotherapeutics company focused on the development and commercialization of first-in-class targeted oncolytic virus products for cancer, today announced that the first patient has been treated in a Phase 1/2 clinical trial of JX-594 in patients with metastatic colorectal cancer who have become refractory to chemotherapy and are either refractory to or ineligible for cetuximab.” View full resource at news-medical.net
Most Recently Shared on March 20, 2012 at 3:46 pm By:
News-Medical.Net Health News and Oncology
Oncology News: Jennerex initiates JX-594 plus irinotecan Phase 1/2 trial in metastatic colorectal cancer: Jenner... http://t.co/MlO8mmVx
Don't Sit on Colon Cancer | Facebook
facebook.com — “Don't Sit on Colon Cancer - Description: The Sentara Cancer Network wants to help you learn about colorectal cancer, how you can treat it and how you can encourage your loved ones to be screened for it. Reaching out to a team with the right tools The Sentara Cancer Network takes a team approach, where a handful of experts recommend treatments. They consider all of the options available and closely follow the Commission on Cancer and National Quality Forum care guidelines. Our health... | Fa” View full resource at facebook.com
Most Recently Shared on March 12, 2012 at 1:29 pm By:
Sentara Healthcare Hospital and Healthcare System
Join us on our new Facebook page for colon cancer awareness - Don't Sit on Colon Cancer - http://t.co/HfwN4fGh
Letter: Screenings help reduce colorectal cancer locally | Lubbock Online | Lubbock Avalanche-Journal
lubbockonline.com — “Colorectal cancer is the second leading cause of cancer death in Texas. When detected and treated early it is one of the most preventable and curable cancers. Since the early 2000s the Lubbock Colon Cancer Prevention Task Force led the campaign in our region to reduce colorectal cancer death rates by 50 percent and incidence rates by 40 percent by 2015. These goals are achievable if all men and women age 50 or older are consistently screened with one of the recommended colon tests.” View full resource at lubbockonline.com
Most Recently Shared on October 17, 2011 at 9:15 am By:
Keith Berger Doctor, Internist, Gastroenterologist, and Physician
In the news: Letter: Screenings help reduce colorectal cancer locally - http://t.co/ybtsNut8: Letter: Screenings he... http://t.co/mvwYdmlE
Resectability With Cetuximab Extends Life In Difficult-to-Treat Metastatic Colorectal Cancer
medicalnewstoday.com — “Combining the epidermal growth factor receptor (EGFR) inhibitor cetuximab with conventional chemotherapy improves survival in patients who have had complete resection of colorectal liver metastase” View full resource at medicalnewstoday.com
Most Recently Shared on October 7, 2011 at 3:05 pm By:
Resectability With Cetuximab Extends Life In Difficult-to-Treat Metastatic Colorectal Cancer http://mnt.to/429C #healthnews
Cholesterol drug assessed for preventing colorectal cancer recurrence
physorg.com — “University of Cincinnati (UC) Cancer Institute oncologists are testing whether a widely used cholesterol-reducing drug can help prevent the recurrence of colorectal cancer in patients who have been surgically treated for the disease previously.” View full resource at physorg.com
Most Recently Shared on March 2, 2011 at 4:27 pm By:
Cholesterol drug assessed for preventing colorectal cancer recurrence http://bit.ly/dOMriG
ArQule's ARQ 197 Phase 1 clinical trial results in colorectal cancer presented at ASCO 2011
news-medical.net — “ArQule, Inc. today announced the presentation of Phase 1 results of a clinical trial among patients with metastatic colorectal cancer (CRC) treated with ARQ 197, a selective small molecule inhibitor of the c-MET receptor tyrosine kinase, in combination with irinotecan and cetuximab. ARQ 197 is under development by Daiichi Sankyo Co., Ltd. and ArQule.” View full resource at news-medical.net
Most Recently Shared on January 24, 2011 at 8:18 pm By:
Lung Cancer News: ArQule's ARQ 197 Phase 1 clinical trial results in colorectal cancer presented at ASCO 2011: A... http://bit.ly/hVC6js
Colorectal Cancer | GreenMedInfo | Disease | Natural Medicine | Alternative Medicine
greenmedinfo.com — “GreenMedInfo contains 51 articles on Colorectal Cancer indicating that the following substances may be helpful: Fermented Foods and Beverages, Apples, and Flavonoids” View full resource at greenmedinfo.com
Most Recently Shared on January 22, 2011 at 2:40 pm By:
Sayer Ji CAM and Health Advocate
Can you guess what natural substances are in the top 10 list for preventing and treating Colorectal Cancer? http://fb.me/zh4rnuo4
New long-term survival data from OPUS, CRYSTAL studies demonstrate strong tumor shrinkage of Erbitux
news-medical.net — “Merck Serono, a division of Merck KGaA, Darmstadt, Germany, today highlighted a further analysis of the large randomized Phase II OPUS study demonstrating an association between early tumor shrinkage and long-term median overall survival (OS) of more than 2 years for patients with KRAS wild-type metastatic colorectal cancer (mCRC) treated with Erbitux® (cetuximab) plus FOLFOX standard chemotherapy.” View full resource at news-medical.net
Most Recently Shared on January 19, 2011 at 2:03 pm By:
Lung Cancer News: New long-term survival data from OPUS, CRYSTAL studies demonstrate strong tumor shrinkage of E... http://bit.ly/fJ5zp4
Scientists Discover Genes That Affect Colorectal Cancer Drug
endonurse.com — “Genomic research could help doctors better target a drug widely used to treat colorectal cancer patients, according to a study by Genomic Health Inc. and the Translational Genomics Research Institute (TGen). The drug, oxaliplatin, is widely used in colon cancer. It is used in early disease, following surgery in those cancers that are likely to recur. It is also used in advanced disease to slow progression of the cancer where it has spread to other parts of the body.” View full resource at endonurse.com
Most Recently Shared on January 15, 2011 at 11:52 am By:
Colorectal cancer patients with gene mutation show better response to cancer agent
physorg.com — “Even though the cancer-treatment agent cetuximab is not considered effective treatment for KRAS (a gene)-mutated metastatic colorectal tumors, new research indicates that patients with colorectal cancer not responding to chemotherapy and a certain variation of this gene who were treated with cetuximab ...” View full resource at physorg.com
Most Recently Shared on October 26, 2010 at 9:38 pm By:
Colorectal cancer patients with gene mutation show better response to cancer agent http://bit.ly/dliF4z
Colorectal Cancer Patients with Gene Mutation Show Better Response to Cancer Agent
newswise.com — “Even though the cancer-treatment agent cetuximab is not considered effective treatment for KRAS (a gene)-mutated metastatic colorectal tumors, new research indicates that patients with colorectal cancer not responding to chemotherapy and a certain variation of this gene who were treated with cetuximab had longer overall and progression-free survival than patients with other KRAS-mutations, according to a study in the October 27 issue of JAMA.” View full resource at newswise.com
Most Recently Shared on October 26, 2010 at 8:43 pm By:
newswise Health Communicator and Health News
Colorectal Cancer Patients with Gene Mutation Show Better Response to Cancer Agent: Even though the cancer-treatme... http://bit.ly/aPiu2x
Erbitux-based therapy helps early tumor shrinkage, long-term survival in mCRC patients with KRAS wild-type tumors
news-medical.net — “Merck Serono, a division of Merck KGaA, Darmstadt, Germany has announced that new data presented today at the 35th Congress of the European Society for Medical Oncology (ESMO) have shown that patients with KRAS wild-type metastatic colorectal cancer (mCRC) who experienced early tumor shrinkage (within 8 weeks) during 1st line Erbitux (cetuximab) based treatment lived a median of 28.3 months.” View full resource at news-medical.net
Most Recently Shared on October 12, 2010 at 9:52 am By:
Lung Cancer News: Erbitux-based therapy helps early tumor shrinkage, long-term survival in mCRC patients with KRAS... http://bit.ly/97M9RT
Combination of Biothera's Imprime PGG and Erbitux doubles response rate in colorectal cancer patients
news-medical.net — “The combination of Biothera's experimental drug Imprime PGG® and Erbitux® (cetuximab) doubled the historical overall response rate and the time to progression of second- and third-line metastatic colorectal cancer patients treated with Erbitux monotherapy. The data was released last weekend at the 13th World Congress on Gastrointestinal Cancer at the European Society for Medical Oncology (ESMO).” View full resource at news-medical.net
Most Recently Shared on July 7, 2010 at 10:30 am By:
News-Medical.Net Health News and Oncology
Oncology News: Combination of Biothera's Imprime PGG and Erbitux doubles response rate in colorectal cancer patien... http://bit.ly/c69g2s
Oncology Medical News about Overall Survival Colorectal Neoplasms
mdlinx.com — “Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC)-results from NCIC CTG CO.17: A phase III trial of cetuximab versus best supportive care” View full resource at mdlinx.com
Most Recently Shared on July 7, 2010 at 8:43 am By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Comorbidity, age and overall survival in cetuximab-treated patients with advanced colorectal cancer (ACRC... http://bit.ly/cnaGmy #oncology
Advertisement
